e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Management of infection and tuberculous diseases II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Isoniazid acetylation phenotype in a group of Tunisian patients (about 515 patients)
N. Mehiri, J. Cherif, B. Louzir, S. Fenna, S. B. Amira, M. Beji, J. Daghfous (Tunis, Tunisia)
Source:
Annual Congress 2004 - Management of infection and tuberculous diseases II
Session:
Management of infection and tuberculous diseases II
Session type:
Thematic Poster Session
Number:
3967
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Mehiri, J. Cherif, B. Louzir, S. Fenna, S. B. Amira, M. Beji, J. Daghfous (Tunis, Tunisia). Isoniazid acetylation phenotype in a group of Tunisian patients (about 515 patients). Eur Respir J 2004; 24: Suppl. 48, 3967
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Is female gender a protective factor for NSCLC patients? A follow up study of 20 years of 478 patients
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Specificity of mycobacterial population susceptibility to TB drugs in patients aged 13-17
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002
Does overprescribing antibiotics (abx) put patients (pts) at risk? A two part retrospective study
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Impact of genotype on the course of pulmonary tuberculosis in new cases patients of Armenian population
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005
Study of interralation of 469+14g/c polymorphism of NRAMP1 gene with sputum biochemical characteristics in COPD patients
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017
Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
COPD in women: a particular phenotype
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Compassionate use of bedaquiline in a cohort of Indian drug resistant tuberculosis(DR-TB) patients
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
Source: ERJ Open Res, 4 (1) 00121-2017; 10.1183/23120541.00121-2017
Year: 2018
Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020
Tuberculosis (TB) relapse rate among patients treated with moxifloxacin (m) or ethambutol (E) in the intensive phase of therapy
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Treatment results of 44 patients with MDR-TB
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003
Determination of the type of acetylation in adult patients with lung tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
Exacerbation rates of COPD in hospital patients, population based cases and controls
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013
Levels of histone deacetylace (HDAC) activity in induced sputum of smokers, non smokers and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 129s
Year: 2005
Targeted sequencing of 130 asthma candidate genes and association testing of rare variants with age of onset in Norwegian asthma patients.
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept